Eltorai Adam E M, Baird Grayson L, Pangborn Joshua, Eltorai Ashley Szabo, Antoci Valentin, Paquette Katherine, Connors Kevin, Barbaria Jacqueline, Smeals Kimberly J, Riley Barbara, Patel Shyam A, Agarwal Saurabh, Healey Terrance T, Ventetuolo Corey E, Sellke Frank W, Daniels Alan H
1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
2 Rhode Island Hospital, Providence, USA.
Inquiry. 2018 Jan-Dec;55:46958018794993. doi: 10.1177/0046958018794993.
Despite largely unproven clinical effectiveness, incentive spirometry (IS) is widely used in an effort to reduce postoperative pulmonary complications. The objective of the study is to evaluate the financial impact of implementing IS. The amount of time nurses and RTs spend each day doing IS-related activities was assessed utilizing an online survey distributed to the relevant national nursing and respiratory therapists (RT) societies along with questionnaire that was prospectively collected every day for 4 weeks at a single 10-bed cardiothoracic surgery step-down unit. Cost of RT time to teach IS use to patients and cost of nurse time spent reeducating and reminding patients to use IS were used to calculate IS implementation cost estimates per patient. Per-patient cost of IS implementation ranged from $65.30 to $240.96 for a mean 9-day step-down stay. For the 566 patients who stayed in the 10-bed step-down in 2016, the total estimated cost of implementing IS ranged from $36 959.80 to $136 383.36. Using national survey workload data, per-patient cost of IS implementation costed $107.36 (95% confidence interval [CI], $97.88-$116.98) for a hospital stay of 4.5 days. For the 9.7 million inpatient surgeries performed annually in the United States, the total annual cost of implementing postoperative IS is estimated to be $1.04 billion (95% CI, $949.4 million-$1.13 billion). The cost of implementing IS is substantial. Further efficacy studies are necessary to determine whether the cost is justifiable.
尽管激励性肺量计(IS)的临床有效性在很大程度上未经证实,但它仍被广泛用于减少术后肺部并发症。本研究的目的是评估实施IS的财务影响。通过向相关的全国护理和呼吸治疗师(RT)协会分发在线调查问卷,并在一个拥有10张床位的心胸外科术后监护病房前瞻性地每天收集4周的问卷,来评估护士和RT每天花费在与IS相关活动上的时间量。RT向患者教授IS使用方法的时间成本以及护士花费在重新教育和提醒患者使用IS上的时间成本,被用于计算每位患者的IS实施成本估算。对于平均9天的术后监护期,每位患者的IS实施成本在65.30美元至240.96美元之间。对于2016年在该10张床位术后监护病房住院的566名患者,实施IS的总估计成本在36959.80美元至136383.36美元之间。利用全国调查工作量数据,对于4.5天的住院时间,每位患者的IS实施成本为107.36美元(95%置信区间[CI],97.88美元至116.98美元)。对于美国每年进行的970万例住院手术,实施术后IS的年度总成本估计为10.4亿美元(95%CI,9.494亿美元至11.3亿美元)。实施IS的成本很高。需要进一步的疗效研究来确定该成本是否合理。